Dasatinib ( DrugBank: Dasatinib )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
51	全身性強皮症	1
85	特発性間質性肺炎	1

51. 全身性強皮症

臨床試験数 : 523 / 薬物数 : 608 - (DrugBank : 156) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 215

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00764309 (ClinicalTrials.gov)	January 2009	1/10/2008	Safety Evaluation of Dasatinib in Subjects With Scleroderma Pulmonary Fibrosis	An Open Label Study to Evaluate the Safety of Dasatinibin the Treatment of Scleroderma Pulmonary Int ...	Scleroderma	Drug: dasatinib	Bristol-Myers Squibb	NULL	Completed	18 Years	N/A	All	47	Phase 1/Phase 2	United States

臨床試験数 : 598 / 薬物数 : 435 - (DrugBank : 116) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 210

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02874989 (ClinicalTrials.gov)	December 16, 2016	17/8/2016	Targeting Pro-Inflammatory Cells in Idiopathic Pulmonary Fibrosis: a Human Trial	Targeted Removal of Pro-Inflammatory Cells: An Open Label Human Pilot Study in Idiopathic Pulmonary ...	Idiopathic Pulmonary Fibrosis (IPF)	Drug: Dasatinib + Quercetin;Drug: Placebo	Wake Forest University Health Sciences	Mayo Clinic;The University of Texas Health Science Center at San Antonio	Completed	50 Years	N/A	All	26	Phase 1	United States